Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Developing Topics Session - Developing Topics in Phase 2 Clinical Trials
  • Developing Topics Session
  • Polaris-AD: AR1001 Additional Phase 2 Data And Phase 3 Trial Update With Topline Results Expected Later This Year
  • ICC Auditorium
    Set Timezone

Niels Prins1, Alireza Atri2, SangYun Kim, M.D.,Ph.D.3, Yi Tang4,5, David Greeley6, James A. Rock7, Fred Kim7, Jai Jun Choung4,7, Sharon J. Sha4,8.
1Brain Research Center, Amsterdam, CA, USA, 2Banner Sun Health Research adn Banner Alzheimer's Institutes, AriBio Co., Ltd, Phoenix, AZ, USA, 3Neurology, Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of, 454Xuanwu Hospital Capital Medical University, Beijing, China, 6Northwest Neurological, Tacoma, WA, USA, 7AriBio Co., Ltd, San Diego, CA, USA, 8Neurology & Neurological Sciences, Stanford University, Stanford, CA, USA.
Types
Main Session